Acerta Pharma B.V.
Carsten Schultz-Fademrecht is an accomplished medicinal chemist currently serving as Associate Director of Medicinal Chemistry at Acerta Pharma B.V., a member of the AstraZeneca Group, since August 2022. Previously, Carsten held the position of VP Chemistry at PearlRiver Bio GmbH, part of Centessa Pharmaceuticals, from January 2021 to July 2022, and founded the same company while also serving as VP Chemistry from April 2019 to December 2020. Carsten has extensive experience in medicinal chemistry, having worked as a Medicinal Chemist at Lead Discovery Center GmbH from January 2009 to March 2019, and as a Senior Research Chemist at Organon/Schering-Plough in 2008. Earlier roles include Senior Scientist at IRBM/Merck & Co and postdoctoral positions at Janssen Pharmaceutica N.V. and Imperial College London. Carsten holds a PhD in Organic Chemistry from the University of Münster.
This person is not in any teams
This person is not in any offices